TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer

Clinical trial NCT06532812 · RECRUITING

Trial details

NCT number: NCT06532812
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Carcinoma Breast Cancer Metastatic Breast Cancer Triple Negative

Start date: 2024-08-22
Primary completion: 2025-12-10
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.